Literature DB >> 9515763

Reactivation of herpes simplex virus type 1 in patients with Bell's palsy.

Y Furuta1, S Fukuda, E Chida, T Takasu, F Ohtani, Y Inuyama, K Nagashima.   

Abstract

Reactivation of herpes simplex virus type 1 (HSV-1) has been implicated in the pathogenesis of idiopathic peripheral facial palsy (Bell's palsy). The present study used the polymerase chain reaction (PCR) to analyze the saliva of patients with Bell's palsy for the presence of shed HSV-1. The study involved 47 patients with Bell's palsy, 24 patients with Ramsay Hunt syndrome, and 16 healthy HSV-seropositive volunteers. HSV-1 DNA was not detected in the saliva samples from HSV-seronegative patients. The prevalence of shed HSV-1 in patients with Bell's palsy (50%) was significantly higher than that in healthy volunteers (19%, p<0.05). When saliva samples were tested within 7 days after the onset of palsy, the prevalence of shed HSV-1 in patients with Bell's palsy (40%) was significantly higher than that in patients with Ramsay Hunt syndrome (7%, p<0.05). Furthermore, HSV-1 usually became undetectable by the second week after the onset of Bell's palsy when HSV-1 was detected during the acute phase of the disease. These findings strongly suggest that reactivation of HSV-1 is involved in the pathogenesis Bell's palsy, and indicate that PCR is a useful tool for early diagnosis of HSV-1 reactivation in patients with Bell's palsy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515763     DOI: 10.1002/(sici)1096-9071(199803)54:3<162::aid-jmv3>3.0.co;2-3

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  22 in total

1.  Comparison of acyclovir and famciclovir for the treatment of Bell's palsy.

Authors:  Ho Joong Kim; Sang Hoon Kim; Junyang Jung; Sung Su Kim; Jae Yong Byun; Moon Suh Park; Seung Geun Yeo
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-12       Impact factor: 2.503

2.  Genotyping of clinical herpes simplex virus type 1 isolates by use of restriction enzymes.

Authors:  Peter Norberg; Tomas Bergström; Jan-Ake Liljeqvist
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

3.  [Quantitative analysis of MRI intensity in of the major petrosal nerve in patients with idiopathic facial paralysis].

Authors:  B Kress; F Griesbeck; C Stippich; W Bähren; K Sartor
Journal:  Nervenarzt       Date:  2004-02       Impact factor: 1.214

Review 4.  Salivary biomarkers: toward future clinical and diagnostic utilities.

Authors:  Janice M Yoshizawa; Christopher A Schafer; Jason J Schafer; James J Farrell; Bruce J Paster; David T W Wong
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

5.  Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weakness.

Authors:  Jean Tsai; Randall J Cohrs; Maria A Nagel; Ravi Mahalingam; D Scott Schmid; Alexander Choe; Don Gilden
Journal:  J Neurol Sci       Date:  2011-09-15       Impact factor: 3.181

6.  Detection of human herpesvirus 6 and varicella-zoster virus in tear fluid of patients with Bell's palsy by PCR.

Authors:  A Pitkäranta; H Piiparinen; L Mannonen; M Vesaluoma; A Vaheri
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

7.  Steroid-antivirals treatment versus steroids alone for the treatment of Bell's palsy: a meta-analysis.

Authors:  Yabing Dong; Yong Zhu; Chuan Ma; Huaqiang Zhao
Journal:  Int J Clin Exp Med       Date:  2015-01-15

8.  Treatment of Bell's Palsy Using Monochromatic Infrared Energy: A Report of 2 Cases.

Authors:  Shu Yan Ng; Ming Him E Chu
Journal:  J Chiropr Med       Date:  2014-06

9.  A cell culture model of facial palsy resulting from reactivation of latent herpes simplex type 1.

Authors:  Maggie A Kuhn; Shruti Nayak; Vladimir Camarena; Jimmy Gardner; Angus Wilson; Ian Mohr; Moses V Chao; Pamela C Roehm
Journal:  Otol Neurotol       Date:  2012-01       Impact factor: 2.311

10.  Comparison of facial nerve paralysis in adults and children.

Authors:  Chang Il Cha; Chang Kee Hong; Moon Suh Park; Seung Geun Yeo
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.